In September 2024, Halie received the call every inmate's family dreads. Her father was dead at age 50, found unresponsive in ...

A pathologist told an inquest yesterday that police involvement did not meaningfully contribute to the death of 61-year-old ...

Chronic respiratory diseases (CRDs) account for more than four million deaths annually, ranking as the third leading cause of death worldwide. Despite this immense burden, CRDs remain largely absent ...

Dr James Fox explores the recent movements in the AstraZeneca share price and evaluates whether it's still a good long-term investment opportunity. The post What’s going on with the AstraZeneca share ...

Mobility predicts how well you are aging through strength, balance, and coordination. Four simple at-home tests can reveal ...

The experimental therapy tozorakimab from AstraZeneca was superior to a placebo at reducing the rate of moderate to severe exacerbations, or sudden episodes of symptom worsening, in adults with ...

Health experts have called for immediate, coordinated measures to tackle the growing prevalence of asthma and Chronic Obstructive Pulmonary Disease (COPD) in Nigeria, citing poor awareness, weak ...

The Western Health and Social Care Trust has been criticised over failings in the care of a woman who died at South West ...

This article was produced as a collaboration between Arkansas Advocate and the Investigative Reporting Lab at Yale. EDITOR’S ...

AstraZeneca’s experimental drug tozorakimab has shown promising results in late-stage trials, reducing flare-ups in patients with chronic obstructive pulmonary disease and boosting investor optimism ...

Kevin DiCicco, who turned a stray dog into the star of ‘Air Bud,’ has died of COPD, leaving behind one of the most unlikely ...

AstraZeneca shares rose after the company said a drug candidate met the primary goal in two late-stage trials for a deadly lung disease, clearing the path to seek approval from regulators. The U.K.